difference in tirzepatide and retatrutide vs. Tirzepatide: The Next-Gen GLP-1 Showdown Retatrutide vs. Tirzepatide: Which Works

Published on December 11, 2024 Written by Simona Byler Medically Reviewed by Andrea Sleeth WHNP-BC, MSCP GLP-1 agonist medications have been making some serious waves in the health industry recentlyand for good reason

Both semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) were developed to treat diabetes and were later found to be highly effective for weight loss

Two separate GLP-1 MDL proceedings are currently underway in the Eastern District of Pennsylvania

The 2.5mg starting dose needs just 25 units

The most common side effects include nausea, vomiting, diarrhea, and constipation particularly during initiation and dose escalation